What You Should Know: - COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer care. - Vista will provide biopharmaceutical companies with timely insights from real-world data sources to bring life-saving therapies to market faster. Vista uses automated data abstraction techniques, machine learning algorithms, and medical expert
Read More
dataset
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know: Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months. Parkinson’s Disease Premium Dataset Nearly
Read More
The Patient Data Bill of Rights
While the United States is generally viewed as one of the great nations with a bill of rights, views differ considerably regarding whether the country has an enlightened approach to healthcare; especially contentious is the ability to provide universal, cost-effective access. I believe all patients in the United States should have basic inalienable rights regarding their personal health information. Therefore, I propose this Patient Data Bill of Rights, and believe it should be mandated by
Read More
Addressing the Diversity Challenge in Clinical Research Through Patient Advocacy
Diversity is paramount to the success of clinical research, both ethically and scientifically. Without adequate representation of racial and ethnic minorities, investigators lack an understanding of the safety and efficacy of novel treatments within those groups. From a scientific standpoint, an incomplete dataset hinders drug delivery and the development of breakthrough therapies – but from an ethical standpoint, underrepresentation creates a barrier to treatment options for populations that
Read More
AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity
Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More
Sonde Health Secures $19.25M for Voice-Based Health Monitoring
What You Should Know: - Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. - The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More
Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors
What You Should Know: - Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors. - The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More
New Data on Massive, Sustained Growth of the Health & Wellness Industry
What You Should Know: - In its latest edition of the Product Report, Amplitude Labs dives straight into results obtained from their exclusive Amplitude dataset, which shows how the product landscape has evolved from 2021 to 2022, including the product growth observed across 12 industries and eight countries. - The report also highlights what the data suggests will be the 30 next hottest products across North America, Europe, and Asia-Pacific. Additionally, the report also covers how
Read More
The Gains and Pains of Using AI in the Pharmaceutical Industry
The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
Gradient AI Acquires Healthcare Analytics Business Unit from Prognos Health 
What You Should Know: - Gradient AI, a leading enterprise software provider of artificial intelligence (AI) solutions in the insurance industry, recently announced that it has acquired Prognos Health’s analytics business underwriting unit to leverage data from the company’s large collection of integrated medical records and lab data via its real-world data marketplace. - The acquisition will enable Gradient AI to expand its medical database capabilities by integrating Prognos Health’s data
Read More
